U.S. Congress - S.2516 Food and Drug Administration Safety and Innovation Act
S.2516 - Food and Drug Administration Safety and Innovation Act
An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (11)
All Bill Titles
- Official: An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as reported to senate.
- Short: Biosimilar User Fee Act of 2012 as reported to senate.
- Short: Generic Drug User Fee Amendments of 2012 as reported to senate.
- Short: Medical Device User Fee Amendments of 2012 as reported to senate.
- Short: Prescription Drug User Fee Amendments of 2012 as reported to senate.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| Latest Actions View All Actions [3] | |
|---|---|
| May 7th | |
| May 7th | Committee on Health, Education, Labor, and Pensions. Original measure reported to Senate by Senator Harkin. Without written report. |
| May 7th | Placed on Senate Legislative Calendar under General Orders. Calendar No. 389. |
Vote on This Bill
-
Share This Bill
More Share via Email
